Stock-Based Compensation for Medtronic (MDT)
Stock-Based Compensation for Medtronic (MDT): headline value $451.00M · YoY +9.2%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
MDT
Currently viewingStock-Based CompensationSwitch metric
Latest period
$451.00M
YoY change
+9.2%
5Y CAGR
+7.6%
Peak year (2015)
$439.00M
Latest annual
$429.00M
Stock-Based Compensation history chart for Medtronic (MDT) from 1990 to 2025
Stock-Based Compensation history table for Medtronic (MDT) from 1990 to 2025
| Fiscal year | Period ended | Reported | Stock-Based Compensation | YoY |
|---|---|---|---|---|
| 2025 | $429.00M | +9.2% | ||
| 2024 | $393.00M | +10.7% | ||
| 2023 | $355.00M | -1.1% | ||
| 2022 | $359.00M | +4.4% | ||
| 2021 | $344.00M | +15.8% | ||
| 2020 | $297.00M | +2.4% | ||
| 2019 | $290.00M | -15.7% | ||
| 2018 | $344.00M | -1.1% | ||
| 2017 | $348.00M | -7.4% | ||
| 2016 | $376.00M | -14.4% | ||
| 2015 | $439.00M | +202.8% | ||
| 2014 | $145.00M | -4.6% | ||
| 2013 | $152.00M | -5.6% | ||
| 2012 | $161.00M | -18.7% | ||
| 2011 | $198.00M | -12.4% | ||
| 2010 | $226.00M | -4.6% | ||
| 2009 | $237.00M | +9.2% | ||
| 2008 | $217.00M | — | ||
| 2007 | $0 | — | ||
| 2006 | $0 | — | ||
| 2005 | $0 | — | ||
| 2004 | $0 | — | ||
| 2003 | $0 | — | ||
| 2002 | $0 | — | ||
| 2001 | $0 | — | ||
| 2000 | $0 | — | ||
| 1999 | $0 | — | ||
| 1998 | $0 | — | ||
| 1997 | $0 | — | ||
| 1996 | $0 | — | ||
| 1995 | $0 | — | ||
| 1994 | $0 | — | ||
| 1993 | $0 | — | ||
| 1992 | $0 | — | ||
| 1991 | $0 | — | ||
| 1990 | $0 | — |
Stock-Based Compensation values are taken from Medtronic's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
The 2025 reading of Medtronic (MDT) stock-based compensation is $429.00M – grew 9.2% year-over-year.
Through 2020–2025 (5 years), Medtronic stock-based compensation delivered a +7.6% annualised rate; with the latest reading among the more recent periods of the dataset.
2015 marks the peak stock-based compensation at $439.00M, with the historical low of $0 recorded in 1990.
Medtronic (MDT) sits 5th of 8 Healthcare peers we track on this metric, against a peer median of $313.00M.
Medtronic Stock-Based Compensation by Year
Medtronic Stock-Based Compensation 2025: $429.00M
Medtronic stock-based compensation in 2025 was $429.00M, grew 9.2% from 2024.
Medtronic Stock-Based Compensation 2024: $393.00M
Medtronic stock-based compensation in 2024 was $393.00M, grew 10.7% from 2023.
Medtronic Stock-Based Compensation 2023: $355.00M
Medtronic stock-based compensation in 2023 was $355.00M, edged down 1.1% below 2022.
Medtronic Stock-Based Compensation 2022: $359.00M
Medtronic stock-based compensation in 2022 was $359.00M, edged up 4.4% from 2021.
Medtronic Stock-Based Compensation 2021: $344.00M
Medtronic stock-based compensation in 2021 was $344.00M.
See more financial history for Medtronic (MDT).
Sector peers — Stock-Based Compensation
Companies in the same sector as Medtronic, ranked by their latest stock-based compensation.
| Company | Stock-Based Compensation | Sector |
|---|---|---|
| Johnson & Johnson (JNJ) | $1.35B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $971.00M | Healthcare |
| AbbVie Inc. (ABBV) | $955.00M | Healthcare |
| Eli Lilly and Company (LLY) | $626.00M | Healthcare |
| AstraZeneca PLC (AZN) | $0 | Healthcare |
| Merck & Co., Inc. (MRK) | $0 | Healthcare |
| Amgen Inc. (AMGN) | $0 | Healthcare |
| Novo Nordisk A/S (NVO) | $0 | Healthcare |
Frequently asked questions
What is Medtronic's stock-based compensation?
Latest reported stock-based compensation for Medtronic (MDT) is $451.00M (period ending January 23, 2026).
How has Medtronic stock-based compensation changed year-over-year?
Medtronic (MDT) stock-based compensation changed +9.2% year-over-year on the latest annual filing.
What is the long-term growth rate of Medtronic stock-based compensation?
Medtronic (MDT) stock-based compensation compound annual growth rate is +7.6% over the most recent 5 years available.
When did Medtronic stock-based compensation hit its highest annual value?
Medtronic stock-based compensation reached its highest annual value of $439.00M in 2015.
What was Medtronic stock-based compensation in 2024?
Medtronic (MDT) stock-based compensation in 2024 was $393.00M.
What was Medtronic stock-based compensation in 2025?
Medtronic (MDT) stock-based compensation in 2025 was $429.00M.
Metrics overview
Pick a metric for charts, filings and peers — each row shows the latest TTM or most-recent-quarter value.
Explore more
MDT Overview
Company profile, financial tools, and key metrics
MDT Revenue Counter
Earns $1,125 every second. See per minute, hour, and day.
MDT Earnings Counter
Earns $146.31 per second net profit. See per minute, hour, and day.
MDT Economic Scale
Exceeds El Salvador's GDP. Compare with world economies.
MDT What If Invested
What if you had invested $1,000? See historical returns from any date.
MDT How It Makes Money
Discover visual breakdown of $35.48B in revenue — where it comes from and where it goes.
MDT Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
MDT Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
MDT Daily Price Character
Steady · 48.1% historical win rate (green days). Streaks & record days.
MDT Buybacks
0.68% TTM buyback yield. Shareholder yield & SBC comparison.
MDT Stock Split History
7 splits on record. Dates, ratios, and cumulative multiple.
MDT Dividend Profile
Yield: 3.58%. Safety: 7/8. See full history.
MDT Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
MDT Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.